310 related articles for article (PubMed ID: 17065397)
1. Mu opioid receptor and orexin/hypocretin mRNA levels in the lateral hypothalamus and striatum are enhanced by morphine withdrawal.
Zhou Y; Bendor J; Hofmann L; Randesi M; Ho A; Kreek MJ
J Endocrinol; 2006 Oct; 191(1):137-45. PubMed ID: 17065397
[TBL] [Abstract][Full Text] [Related]
2. Effects of acute "binge" cocaine on preprodynorphin, preproenkephalin, proopiomelanocortin, and corticotropin-releasing hormone receptor mRNA levels in the striatum and hypothalamic-pituitary-adrenal axis of mu-opioid receptor knockout mice.
Zhou Y; Spangler R; Schlussman SD; Yuferov VP; Sora I; Ho A; Uhl GR; Kreek MJ
Synapse; 2002 Sep; 45(4):220-9. PubMed ID: 12125043
[TBL] [Abstract][Full Text] [Related]
3. Effects of acute "binge" cocaine on mRNA levels of mu opioid receptor and neuropeptides in dopamine D1 or D3 receptor knockout mice.
Zhou Y; Adomako-Mensah J; Yuferov V; Ho A; Zhang J; Xu M; Kreek MJ
Synapse; 2007 Jan; 61(1):50-9. PubMed ID: 17068774
[TBL] [Abstract][Full Text] [Related]
4. Amygdalar vasopressin mRNA increases in acute cocaine withdrawal: evidence for opioid receptor modulation.
Zhou Y; Bendor JT; Yuferov V; Schlussman SD; Ho A; Kreek MJ
Neuroscience; 2005; 134(4):1391-7. PubMed ID: 16039786
[TBL] [Abstract][Full Text] [Related]
5. Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"-pattern cocaine administration and chronic withdrawal.
Zhou Y; Spangler R; LaForge KS; Maggos CE; Ho A; Kreek MJ
J Pharmacol Exp Ther; 1996 Oct; 279(1):351-8. PubMed ID: 8859013
[TBL] [Abstract][Full Text] [Related]
6. Reduced hypothalamic POMC and anterior pituitary CRF1 receptor mRNA levels after acute, but not chronic, daily "binge" intragastric alcohol administration.
Zhou Y; Franck J; Spangler R; Maggos CE; Ho A; Kreek MJ
Alcohol Clin Exp Res; 2000 Oct; 24(10):1575-82. PubMed ID: 11045867
[TBL] [Abstract][Full Text] [Related]
7. Effects of selective D1- or D2-like dopamine receptor antagonists with acute "binge" pattern cocaine on corticotropin-releasing hormone and proopiomelanocortin mRNA levels in the hypothalamus.
Zhou Y; Spangler R; Yuferov VP; Schlussmann SD; Ho A; Kreek MJ
Brain Res Mol Brain Res; 2004 Nov; 130(1-2):61-7. PubMed ID: 15519677
[TBL] [Abstract][Full Text] [Related]
8. Effects of cocaine place conditioning, chronic escalating-dose "binge" pattern cocaine administration and acute withdrawal on orexin/hypocretin and preprodynorphin gene expressions in lateral hypothalamus of Fischer and Sprague-Dawley rats.
Zhou Y; Cui CL; Schlussman SD; Choi JC; Ho A; Han JS; Kreek MJ
Neuroscience; 2008 Jun; 153(4):1225-34. PubMed ID: 18436386
[TBL] [Abstract][Full Text] [Related]
9. Immediate withdrawal from chronic "binge" cocaine administration increases mu-opioid receptor mRNA levels in rat frontal cortex.
Bailey A; Yuferov V; Bendor J; Schlussman SD; Zhou Y; Ho A; Kreek MJ
Brain Res Mol Brain Res; 2005 Jun; 137(1-2):258-62. PubMed ID: 15950784
[TBL] [Abstract][Full Text] [Related]
10. Alterations in corticotropin-releasing factor and vasopressin content in rat brain during morphine withdrawal: correlation with hypothalamic noradrenergic activity and pituitary-adrenal response.
Milanés MV; Laorden ML; Chapleur-Château M; Burlet A
J Pharmacol Exp Ther; 1998 May; 285(2):700-6. PubMed ID: 9580616
[TBL] [Abstract][Full Text] [Related]
11. Possible involvement of orexin in the stress reaction in rats.
Ida T; Nakahara K; Murakami T; Hanada R; Nakazato M; Murakami N
Biochem Biophys Res Commun; 2000 Apr; 270(1):318-23. PubMed ID: 10733946
[TBL] [Abstract][Full Text] [Related]
12. Circadian alteration in neurobiology during protracted opiate withdrawal in rats.
Li SX; Liu LJ; Jiang WG; Sun LL; Zhou SJ; Le Foll B; Zhang XY; Kosten TR; Lu L
J Neurochem; 2010 Oct; 115(2):353-62. PubMed ID: 20738730
[TBL] [Abstract][Full Text] [Related]
13. Chronic morphine exposure during puberty induces long-lasting changes in opioid-related mRNA expression in the mediobasal hypothalamus.
Byrnes EM
Brain Res; 2008 Jan; 1190():186-92. PubMed ID: 18083149
[TBL] [Abstract][Full Text] [Related]
14. Single dose of morphine influences plasma corticosterone and gene expression of main NMDA receptor subunit in the adrenal gland but not in the hippocampus.
Pirnik Z; Schwendt M; Jezova D
Endocr Regul; 2001 Dec; 35(4):187-93. PubMed ID: 11858765
[TBL] [Abstract][Full Text] [Related]
15. Lack of effect of chronic morphine treatment and naloxone-precipitated withdrawal on tyrosine hydroxylase, galanin, and neuropeptide Y mRNA levels in the rat locus coeruleus.
Holmes PV; de Bartolomeis A; Koprivica V; Crawley JN
Synapse; 1995 Mar; 19(3):197-205. PubMed ID: 7540319
[TBL] [Abstract][Full Text] [Related]
16. Congenital vasopressin deficiency and acute and chronic opiate effects on hypothalamo-pituitary-adrenal axis activity in Brattleboro rats.
Domokos A; Mergl Z; Barna I; Makara GB; Zelena D
J Endocrinol; 2008 Jan; 196(1):113-21. PubMed ID: 18180322
[TBL] [Abstract][Full Text] [Related]
17. Regulation of proopiomelanocortin gene transcription during single and repeated immobilization stress.
Noguchi T; Makino S; Maruyama H; Hashimoto K
Neuroendocrinology; 2006; 84(1):21-30. PubMed ID: 17085933
[TBL] [Abstract][Full Text] [Related]
18. Long-lasting up-regulation of orexin receptor type 2 protein levels in the rat nucleus accumbens after chronic cocaine administration.
Zhang GC; Mao LM; Liu XY; Wang JQ
J Neurochem; 2007 Oct; 103(1):400-7. PubMed ID: 17623047
[TBL] [Abstract][Full Text] [Related]
19. Hypothalamic-pituitary-adrenal activity and pro-opiomelanocortin mRNA levels in the hypothalamus and pituitary of the rat are differentially modulated by acute intermittent morphine with or without water restriction stress.
Zhou Y; Spangler R; Maggos CE; Wang XM; Han JS; Ho A; Kreek MJ
J Endocrinol; 1999 Nov; 163(2):261-7. PubMed ID: 10556776
[TBL] [Abstract][Full Text] [Related]
20. Comparison of melanin-concentrating hormone and hypocretin/orexin mRNA expression patterns in a new parceling scheme of the lateral hypothalamic zone.
Swanson LW; Sanchez-Watts G; Watts AG
Neurosci Lett; 2005 Oct; 387(2):80-4. PubMed ID: 16084021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
